American Heart Journal
Volume 144, Issue 5 , Pages 753-759, November 2002

Carotid artery intimal-medial thickness: Indicator of atherosclerotic burden and response to risk factor modification☆☆

Ann Arbor, Mich, and Cleveland, Ohio

From the aDivision of Cardiology, University of Michigan, Ann Arbor, Mich, and the bDepartment of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Received 5 June 2001; accepted 12 March 2002.

Abstract 

Background A number of studies have used B-mode ultrasound to measure carotid intimal-medial thickness as an indicator of the severity of carotid atherosclerosis. Methods We reviewed the available data on carotid intimal-medial thickness in defining severity of atherosclerosis, with the use of high-quality studies that addressed clinical end points. Results Data from multiple studies demonstrate a high degree of reproducibility in measurements of intimal-medial thickness. A number of agents that include 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, angiotensin-converting enzyme inhibitors, and insulin sensitizers reduce carotid intimal-medial thickness and cardiovascular events, such as myocardial infarction and stroke. Conclusions In this review article, various methods of measuring carotid intimal-medial thickness are examined and critiqued. In addition, the effects of various lifestyle modifications and therapeutic agents on intimal-medial thickness and cardiovascular end points are evaluated. (Am Heart J 2002;144:753-9.)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Reprint requests: Jay S. Yadav, MD, Cleveland Clinic Foundation, Department of Cardiology, F25, 9500 Euclid Ave, Cleveland, OH 44195.

☆☆ E-mail: yadavj@ccf.org

PII: S0002-8703(02)00182-5

doi:10.1067/mhj.2002.124865

American Heart Journal
Volume 144, Issue 5 , Pages 753-759, November 2002